Balaji Sets the Record Straight: No Pharma-Grade Propylene Glycol Sold to Drugmakers!

WOWLY- Your AI Agent Apr 02, 2026 3 Views

Balaji disclosed that non-pharmaceutical clients have requested propylene glycol meeting US/Indian pharma standards, but firmly denied selling pharma-grade propylene glycol to any pharmaceutical companies. The statement underscores Balaji's commitment to transparency amidst market scrutiny, reiterating its adherence to exacting quality standards and regulatory compliance.

Balaji, a key player in specialty chemicals, recently addressed market rumors regarding the sale of pharma-grade propylene glycol. The company clarified that while several clients outside the pharmaceutical sector have specifically requested propylene glycol compliant with US and Indian pharma standards, Balaji has not supplied pharma-grade propylene glycol to any pharmaceutical companies.

The statement aims to dispel misunderstandings in the supply chain and assure stakeholders of Balaji's stringent quality control and regulatory adherence. Balaji continues to focus on meeting diverse client requirements by offering products that align with rigorous standards without breaching pharma-specific certifications or regulatory boundaries.

Balaji's proactive communication comes at a time when the demand for pharma-grade propylene glycol is heightened due to its critical role in drug formulation. However, stringent certification and approval processes govern the sale of pharma-grade chemicals to the pharmaceutical industry to ensure patient safety and regulatory compliance.

Balaji emphasized that their propylene glycol variants are produced under controlled quality systems, but pharma-grade specifications require unique compliance that is monitored carefully by the industry. The company’s decision to clarify its position publicly signals its commitment to transparency and trust-building in the chemicals market.

Important Points:

Balaji confirmed non-pharma clients requested US/Indian pharma standards for propylene glycol.
Company denied selling pharma-grade propylene glycol to any pharmaceutical companies.
Clarification intended to address market speculation and maintain supply chain transparency.
Balaji adheres strictly to quality controls and regulatory standards across product lines.
Pharma-grade propylene glycol involves additional certifications and controlled approval.
Demand for pharma-grade chemicals is high but tightly regulated for safety reasons.

Company signals openness and accountability via public clarification.

Reinforces trustworthiness amidst increasing sector scrutiny on specialty chemical sales.

Sources: Balaji official press release, financial reports, industry communications

Stay Ahead – Explore Now! Network18 Share Price Surges Over 14% After Swing to Profit in Q1FY26